Physician profile
Gregory Worley
NPI 1356340939
$11,410.09
in general payments reported to CMS, 2019-2025
43 companies · $1,358 in 2025
The $1,358 reported for 2025 was more than what 76% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $294 · 2021: $597 · 2022: $6,478 · 2023: $781 · 2024: $1,623 · 2025: $1,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,271 · Travel and Lodging: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,271.11 |
| Travel and Lodging | $490.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,372.48 | 2022 | |
| Legacy Ortho LLC | $1,517.38 | 2022-2025 | |
| Smith+Nephew, INC. | $1,512.86 | 2020-2025 | Grafix Pl, Stravix Pl, Grafix |
| Stryker Corporation | $699.70 | 2019-2025 | Easyfuse, Limflow System, Dart-Fire |
| Kerecis Limited | $432.77 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Musculoskeletal Transplant Foundation INC. | $369.09 | 2024 | |
| Paragon 28, INC. | $350.71 | 2021-2025 | Portfolio, Gorilla, Tenotac |
| Reprise Biomedical, INC. | $249.80 | 2024-2025 | Miro3d, Miro3d Fibers, Mirotract |
| Organogenesis INC. | $178.38 | 2021-2024 | Puraply |
| Aroa Biosurgery Incorporated | $139.95 | 2022-2024 | |
| Reapplix INC. | $137.17 | 2024-2025 | 3c Patch Kit - Box |
| Depuy Synthes Sales INC. | $112.61 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $103.35 | 2020-2024 | Nuzyra |
| Treace Medical Concepts, INC. | $97.52 | 2024-2025 | |
| Averitas Pharma INC. | $92.30 | 2023-2024 | Qutenza |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $90.81 | 2019-2021 | |
| Biotissue Holdings INC. | $85.93 | 2025 | |
| Zyla Life Sciences, INC. | $77.79 | 2019-2020 | |
| Horizon Therapeutics Plc | $76.38 | 2019-2021 | |
| Abbvie INC. | $65.13 | 2023 | Dalvance |
| Bioventus LLC | $62.27 | 2021-2023 | |
| Ibsa Pharma INC. | $53.32 | 2023-2024 | Licart, Tirosint, Tirosint |
| Zimmer Biomet Holdings, INC. | $51.44 | 2019-2020 | |
| Alfasigma USA, INC. | $40.17 | 2020-2022 | |
| Nevro Corp. | $36.73 | 2023 | Senza |
| Grt US Holding, INC. | $33.62 | 2021 | |
| Bone Support INC. | $31.78 | 2024 | Cerament G, Ceramentbone Void Filler |
| Mimedx Group, INC. | $29.20 | 2024-2025 | |
| Acera Surgical, INC. | $28.75 | 2024 | Restrata Wound Matrix |
| Dexcom, INC. | $28.61 | 2025 | Dexcom G6 Transmitter |
| Osiris Therapeutics INC. | $27.09 | 2019 | |
| Tactile Systems Technology INC | $26.77 | 2025 | Nimbl, Flexitouch Plus |
| Melinta Therapeutics, LLC | $26.30 | 2019 | |
| Assertio Therapeutics, INC. | $24.75 | 2020 | |
| Ethicon US, LLC | $20.24 | 2020 | |
| Kci USA, INC. | $20.16 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $18.88 | 2025 | Exparel |
| Wright Medical Technology, INC. | $18.06 | 2020 | |
| Baxter Healthcare | $16.00 | 2022 | |
| Hydrofera LLC | $15.00 | 2025 | Cutimed Sorbion |
| Acell, INC. | $13.84 | 2019 | |
| Triad Life Sciences INC. | $12.74 | 2021 | |
| Merck Sharp & Dohme LLC | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Worley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.